Cytarabine Injection, Solution
Product Images NDC 71288-108

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 71288-108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Sag0e 0001 01)

Chemical structure of Cytarabine showing its molecular formula C9H13N3O5 and molecular weight 243.22. The diagram includes the pyrimidine base linked to a sugar moiety with hydroxyl groups depicted.*

FDA Label Image

Figure (Sag0e 0001 02)

Cytarabine Injection 100 mg per 5 mL (20 mg per mL) single-dose vial label by Meitheal Pharmaceuticals Inc. It is sterile, nonpyrogenic, preservative-free isotonic solution for intravenous, intrathecal, and subcutaneous use. The label includes storage instructions, manufacturer details, and caution regarding its cytotoxic nature.*

FDA Label Image

Figure (Sag0e 0001 03)

Packaging label for Cytarabine Injection 100 mg per 5 mL (20 mg per mL) in a box containing 5 single-dose vials. The label specifies use for intravenous, intrathecal, and subcutaneous administration only, with a caution stating it is a cytotoxic agent. The product is labeled with NDC 71288-108 and manufactured by Meitheal Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.